IPP Bureau
Aarti Drugs receives EIR from USFDA for Tarapur API facility
By IPP Bureau - December 26, 2024
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
SVU to organise International Conference on Clinical Translation of Biomaterial-based Therapeutics and Devices on 6-7 Feb, 2025
By IPP Bureau - December 26, 2024
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Antara partners with Dr. Lal PathLabs to strengthen its geriatric care services
By IPP Bureau - December 24, 2024
This curated geriatric care package - Varishtha Aarogya Vardaan -- includes a comprehensive range of essential blood tests specifically curated for seniors.
Tejnaksh Healthcare’s MD granted Indian patent for Pflow
By IPP Bureau - December 24, 2024
Pflow is a revolutionary, disposable, and portable home based urine flow measurement test
Ikena Oncology and Inmagene Biopharmaceuticals announce agreement for merger
By IPP Bureau - December 24, 2024
The transaction is expected to result in approximately $175 million to support further development of IMG-007
BASF sells food and health performance ingredients business to Louis Dreyfus Company
By IPP Bureau - December 24, 2024
Divestment is part of BASF’s strategic portfolio optimization
Syensqo and Emulseo collaborate to advance microfluidic technology in healthcare sector
By IPP Bureau - December 24, 2024
Exploring new opportunities within the fast-growing market of microfluidics
KRAIBURG TPE's solutions upraises healthcare products for higher functionality
By IPP Bureau - December 22, 2024
The TPE Tourniquet and TPE Esmark Bandages are renowned for their single-use design,
Alembic Pharmaceuticals receives USFDA final approval for Divalproex Sodium Delayed-Release Capsules
By IPP Bureau - December 22, 2024
Divalproex Sodium Delayed-Release Capsules USP, 125 mg have an estimated market size of US$ 61.1 million for twelve months ending September 2024 according to IQVIA
Briefs: Laurus Bio and Cupid
By IPP Bureau - December 22, 2024
Laurus Labs informs that Eight Roads Ventures and F-Prime Capital (Investors) have together invested Rs. 120 crores in Laurus Bio
Shilpa Medicare’s Unit VII, Nacharam, Hyderabad receives GMP certificate from EMA, Austria
By IPP Bureau - December 22, 2024
The company has received the GMP Certification after successful closure of the inspection
CuraTeQ Biologics receives approval for oncology biosimilar Bevqolva from UK's MHRA
By IPP Bureau - December 22, 2024
Bevqolva 25 mg/mL concentrate for infusion will be available in 4 mL (100 mg) and 16 mL (400 mg) single-use vials for infusion into veins
Reliance Digital Health Ltd to acquire 45% in Health Alliance Group
By IPP Bureau - December 22, 2024
The investment will empower RDHL to develop a virtual diagnostic and care platform, expanding access to healthcare for underserved communities
Briefs: Gandhar Oil Refinery India, FDC and Apitoria Pharma
By IPP Bureau - December 22, 2024
FDC Ltd has received final approval from USFDA for the company's Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets
